Neurology News and Research

Latest Neurology News and Research

New brain mapping model could improve success rate of transcranial magnetic stimulation

Brain researchers from the Perelman School of Medicine at the University of Pennsylvania have developed a new brain mapping model which could improve the success rate of transcranial magnetic stimulation (TMS) in treating conditions including depression, neuropathic pain, and stroke.

23 Apr 2015

UC San Diego, Scripps partner to improve patient care, physician training and research in hospice medicine

UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year agreement, Scripps will work with UC San Diego to provide outpatient and inpatient hospice care for UC San Diego patients, allowing UC San Diego physicians to better coordinate post-acute care for patients with chronic illness.

23 Apr 2015

New treatment shows promise in easing symptoms of Parkinson's disease

To date, a cure for Parkinson's disease remains elusive for the more than 50,000 Americans diagnosed yearly, despite decades of intensive study. But a newly approved treatment that might help ease the symptoms of Parkinson's has shown remarkable promise.

22 Apr 2015

New research examines what happens when MS patients discontinue their medication

New research led by NYU Langone Medical Center examines what happens when a patient with multiple sclerosis (MS) who is clinically stable stops taking their medication.

22 Apr 2015

Astellas, Potenza collaborate to develop immuno-oncology therapeutics for patients with certain cancers

Astellas Pharma Inc. and Potenza Therapeutics, Inc., a biotechnology company developing a portfolio of immuno-oncology programs, today announced an exclusive research and development collaboration.

22 Apr 2015

Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

Upsher-Smith Laboratories, Inc. presented data from a 52-week, open-label extension study (PREVAIL OLE) showing that Qudexy XR (topiramate) extended-release capsules offered a long-term adjunctive treatment option with a favorable tolerability profile for a high proportion of patients with refractory partial-onset seizures (POS).

21 Apr 2015

BrainStorm presents positive results from NurOwn phase 2a study in ALS at AAN annual meeting

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, is presenting results from its phase 2a study of NurOwn in amyotrophic lateral sclerosis (ALS) at a poster session today at the American Academy of Neurology annual meeting, taking place in Washington D.C.

21 Apr 2015

Montefiore and Einstein researchers to present new findings on neurological disorders at AAN 2015

Researchers from Montefiore Health System and Albert Einstein College of Medicine will present new findings on how to effectively treat migraine, and forecast the onset of pain in a number of neurological conditions including dementia in older adults.

21 Apr 2015

UCLA-led stroke study selected as one of 10 most outstanding research papers by CRF

A UCLA-led study on improving stroke care was selected by the Clinical Research Forum (CRF) as one of the 10 most outstanding research papers written by teams from across the nation in 2014. The organization highlighted the papers at its fourth annual awards ceremony in Washington, D.C. on April 16.

21 Apr 2015

Study: Extending natalizumab treatment effective in preventing MS symptoms

In a study of 1,964 patients with multiple sclerosis (MS) led by researchers at the NYU Langone Multiple Sclerosis Comprehensive Care Center, extending the dose of natalizumab from 4 weeks up to 8 weeks was shown to be well-tolerated and effective in patients, and resulted in no cases of the potentially fatal side effect progressive multifocal leukoencephalopathy (PML).

21 Apr 2015

Clinical trials show benefits of endovascular therapy for acute ischemic strokes

Anthony J. Furlan, MD, Chairman of Neurology and Co-Director of the Neurological Institute at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine, who writes an accompanying editorial for five studies about endovascular stroke therapy published simultaneously in the New England Journal of Medicine (NEJM.org">NEJM.org April 17), says these randomized clinical trials represent a breakthrough in showing the benefits of endovascular therapy for acute ischemic strokes.

20 Apr 2015

Study confirms benefits of removing blood clots after stroke

A technique that removes blood clots from large brain blood vessels reduced disability after stroke in a trial conducted in Catalonia, Spain, and co-led by an expert from the University of Pittsburgh School of Medicine.

20 Apr 2015

Endovascular therapy best treatment option for stroke patients

A research paper published in the New England Journal of Medicine (NEJM) today confirms earlier findings that a procedure called endovascular therapy (ET) for ischemic stroke is the best treatment option for many patients by reducing the incidents of disability.

17 Apr 2015

Majority of patients who survive cardiac arrest experience cognitive problems

Half of all patients who survive a cardiac arrest experience problems with cognitive functions such as memory and attention.

17 Apr 2015

Study shows epilepsy drug can protect vision of MS patients

A drug commonly taken to prevent seizures in epilepsy may surprisingly protect the eyesight of people with multiple sclerosis (MS), according to a study released today that will be presented at the American Academy of Neurology's 67th Annual Meeting in Washington, DC, April 18 to 25, 2015.

17 Apr 2015

Study could lead to new therapeutic targets for treating Huntington's disease

An international study led by researchers from Université Laval and CHU de Québec-Université Laval has identified significant vascular changes in the brains of people with Huntington's disease. This breakthrough, the details of which are published in the most recent issue of Annals of Neurology, will have significant implications for our understanding of the disease and could open the door to new therapeutic targets for treating this fatal neurodegenerative condition.

17 Apr 2015

Study provides detailed brain map of language impairments in aphasia after stroke

The exchange of words, speaking and listening in conversation, may seem unremarkable for most people, but communicating with others is a challenge for people who have aphasia, an impairment of language that often happens after stroke or other brain injury.

16 Apr 2015

New research links sleep apnea, heavy snoring with premature cognitive decline

Heavy snoring and sleep apnea may be linked to memory and thinking decline at an earlier age, according to a new study published in the April 15, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Apr 2015

New longer-term data on Genzyme's relapsing MS treatments to be presented at AAN 2015

Genzyme, a Sanofi company, announced today that new longer-term data on its relapsing multiple sclerosis treatments, Aubagio (teriflunomide) and Lemtrada (alemtuzumab), will be featured during the 67th annual meeting of the American Academy of Neurology being held in Washington, D.C. April 18-25.

15 Apr 2015

MEMREHAB trial shows that treatment with mSMT may be adversely affected by cognitive dysfunction

Kessler Foundation researchers published a subanalysis of their MEMREHAB trial, which shows that treatment with the modified Story Memory Technique (mSMT) may be affected by cognitive dysfunction. Investigators looked at the influence of processing speed on benefits of the mSMT, a 10-session cognitive intervention protocol shown to improve new learning and memory in individuals with MS.

13 Apr 2015

Neurology News and Research

Latest Neurology News and Research

New brain mapping model could improve success rate of transcranial magnetic stimulation

UC San Diego, Scripps partner to improve patient care, physician training and research in hospice medicine

New treatment shows promise in easing symptoms of Parkinson's disease

New research examines what happens when MS patients discontinue their medication

Astellas, Potenza collaborate to develop immuno-oncology therapeutics for patients with certain cancers

Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

BrainStorm presents positive results from NurOwn phase 2a study in ALS at AAN annual meeting

Montefiore and Einstein researchers to present new findings on neurological disorders at AAN 2015

UCLA-led stroke study selected as one of 10 most outstanding research papers by CRF

Study: Extending natalizumab treatment effective in preventing MS symptoms

Clinical trials show benefits of endovascular therapy for acute ischemic strokes

Study confirms benefits of removing blood clots after stroke

Endovascular therapy best treatment option for stroke patients

Majority of patients who survive cardiac arrest experience cognitive problems

Study shows epilepsy drug can protect vision of MS patients

Study could lead to new therapeutic targets for treating Huntington's disease

Study provides detailed brain map of language impairments in aphasia after stroke

New research links sleep apnea, heavy snoring with premature cognitive decline

New longer-term data on Genzyme's relapsing MS treatments to be presented at AAN 2015

MEMREHAB trial shows that treatment with mSMT may be adversely affected by cognitive dysfunction

Aneuro: Solutions for in vivo Electrophysiology Recordings eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Neurology News and Research

Latest Neurology News and Research

Aneuro: Solutions for in vivo Electrophysiology Recordings eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in